CAR T-cell therapy genetically alters a patient's immune cells to fight certain cancers like lymphoma and leukemia.

CAR T-cell therapy has been hugely successful in treating certain types of tumours, and stiffening up cancer cells beforehand could make it even more effective ...

You might think of cancer as a mass of rogue cells that grow uncontrollably. But cancer is more organized and strategic than ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

Anocca AB (‘Anocca’ or the ‘Company’), a clinical-stage biotechnology company developing advanced T-cell immunotherapies, today announced the successful dosing of the first patients across multiple ...

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before. This breakthrough may help explain why immunotherapy works for some ...

Dr. André Veillette told Newsweek that their findings could help patients who do not respond to current cancer treatments.

The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that they could be more potent and less toxic than the standard mix of cells ...

In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of ...

A study from the University of Calgary shows that removing a single gene makes colon cancer cells a target for immunotherapy ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...